ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,514.00
      1.00%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      67,869.97
      -0.06%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Stoke Therapeutics Inc (STOK) Quote

      Stoke Therapeutics Inc

      Stoke Therapeutics Inc (STOK)

      NASDAQ
      15.86
      1.30
      (8.93%)
      Closed July 27 4:00PM
      Delayed by 15 minutes
      15.83
      -0.03
      (-0.19%)
      After Hours: 6:59PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      15.83
      Bid
      15.62
      Ask
      16.50
      Volume
      942,935
      14.785 Day's Range 15.97
      3.35 52 Week Range 17.58
      Market Cap
      825.057M
      Previous Close
      14.56
      Open
      14.90
      Last Trade
      87
      @
      15.83
      Last Trade Time
      Financial Volume
      $ 14,519,020
      VWAP
      15.3977
      Average Volume (3m)
      758,272
      Shares Outstanding
      52,119,860
      Dividend Yield
      -
      PE Ratio
      -7.88
      Earnings Per Share (EPS)
      -2.01
      Revenue
      8.78M
      Net Profit
      -104.7M

      About Stoke Therapeutics Inc

      Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively... Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.stoketherapeutics.com
      Headquarters
      Dover, Delaware, USA
      Founded
      1970
      Stoke Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker STOK. The last closing price for Stoke Therapeutics was $14.56. Over the last year, Stoke Therapeutics shares have traded in a share price range of $ 3.35 to $ 17.58.

      Stoke Therapeutics currently has 52,119,860 shares outstanding. The market capitalization of Stoke Therapeutics is $758.87 million. Stoke Therapeutics has a price to earnings ratio (PE ratio) of -7.88.

      Stoke Therapeutics (STOK) Options Flow Summary

      STOK Options Flow

      Overall Flow

      Bullish

      Net Premium

      193k

      Calls / Puts

      100.00%

      Buys / Sells

      0.00%

      OTM / ITM

      0.00%

      Sweeps Ratio

      0.00%

      STOK Latest News

      More News

      Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

      Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine, today announced that, effective on...

      July 16 2024
      Business Wire

      Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

      Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today...

      June 18 2024
      Business Wire

      Form S-3 - Registration statement under Securities Act of 1933

      June 13 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 07 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 07 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 07 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 07 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 07 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      June 06 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 05 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      12.1415.631848064313.6915.9713.4554461514.54728176CS
      42.2316.397058823513.615.9712.2467311613.83389981CS
      123.8331.91666666671217.5811.0175827214.17193777CS
      2610.95224.3852459024.8817.584.0997993512.35111506CS
      529.51150.4746835446.3217.583.3562181110.75705342CS
      156-14.96-48.587203637530.7933.06353.3538997112.54054007CS
      260-7.22-31.323210412123.0571.583.3529641017.07619069CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      WINTWindtree Therapeutics Inc
      $ 8.24
      (150.46%)
      		48.57M
      BFIBurgerFi International Inc
      $ 0.4206
      (97.37%)
      		313.59M
      NBSTWNewbury Street Acquisition Corporation
      $ 0.1349
      (92.71%)
      		122.1k
      YIBOPlanet Image International Ltd
      $ 2.915
      (53.43%)
      		260.07k
      CREVCarbon Revolution Public Ltd
      $ 9.00
      (45.87%)
      		8.06M
      NMHINatures Miracle Holding Inc
      $ 0.2035
      (-48.06%)
      		7.69M
      TANHTantech Holdings Ltd
      $ 0.2585
      (-47.23%)
      		6.75M
      DXCMDexCom Inc
      $ 64.00
      (-40.66%)
      		53.92M
      PSIGPS International Group Ltd
      $ 1.42
      (-31.40%)
      		716.26k
      POAIPredictive Oncology Inc
      $ 1.36
      (-27.27%)
      		6.02M
      SLNASelina Hospitality PLC
      $ 0.0305
      (-18.88%)
      		408.61M
      BFIBurgerFi International Inc
      $ 0.4206
      (97.37%)
      		313.59M
      NVDANVIDIA Corporation
      $ 113.06
      (0.69%)
      		293.33M
      SQQQProShares UltraPro Short QQQ
      $ 9.10
      (-2.88%)
      		176.49M
      SGMOSangamo Therapeutics Inc
      $ 0.8612
      (28.15%)
      		123.71M

      STOK Discussion

      View Posts
      Zardiw Zardiw 4 months ago
      $STOK Chart from #DDAmanda - #1 Stock Screener :

      Scans are preset. Push a Button. Find Winners Early:



      Z
      👍️0
      TimeFades TimeFades 4 months ago
      Choppy day shoulda just stuck with my morning short
      👍️0
      TimeFades TimeFades 4 months ago
      Got bullish again and covered
      👍️0
      TimeFades TimeFades 4 months ago
      Short from 12s
      👍️0
      Invest-in-America Invest-in-America 4 months ago
      STOK: "Stoke Therapeutics (NASDAQ:STOK) stock shot up 70% in post-market trading Monday after the company reported positive results from studies for its drug STK-001 in the treatment of children and adolescents with Dravet syndrome, a genetic form of epilepsy. The biotech company said data from two Phase 1/2a studies and two open label extension, or OLE, studies showed “clinically meaningful effects” that included “substantial and durable reductions in convulsive seizure frequency."
      https://seekingalpha.com/news/4083468-stoke-stock-soars-post-market-on-epilepsy-drug-data

      Dravet Syndrome is an extremely RARE disease in the USA. And the above news does NOT specify nor suggest that STOK's (potential) treatment for Dravet Syndrome will or might have any applications for treatment of EPILEPSY at all. (Be very CAREFUL about news like the above.)
      👍️0

      Your Recent History

      NASDAQ
      STOK
      Stoke Therapeutics
      NYSE
      BNL
      Broadstone Net Lease
      USOTC
      CHMN
      Chester Mining (CE)
      Delayed Upgrade Clock